AlexanderS., BrendlerM.: Treatment of uric acid urolothiasis with allopurinol: a xanthine oxidase inibitor. J. Urol., 79: 340: 1967.
2.
BonominiV., BiancaniG., PetrellaA., ZucchelliP.: Considerazioni critiche sulla possibilità di valutare la alternanza funzionale dei glomeruli attraverso le clearances renali. Min. Nefrol., 5: 68: 1968.
3.
DelbarreF., FoglieriniT., LarrieuF., FrugierJ. C.: Effets de l'allopurinol chez le goutteux avec lithiase urinaire urique ou hyper-uraturie. Sem. Hop., 43: 652: 1967.
4.
De VriesA., LibermanU. A., SperlingO., FrankM.: L'allopurinol nella profilassi della litiasi uratica. Ann. of the Reum. Disease, 25: 691: 1966.
5.
ElionG. B., CallahanS. W., HitchingsG. H., RundlesR. W., LaszleT.: Experimental, Clinical and metabolic studies of thiopurines. Canc. Chem. Rep., 16: 197: 1962.
6.
EngelmanK., WattsR. W. E., KlinenbergJ. R., SjoedsmaA., SeegmillerJ. E.: Clinical, physiological and biochemical studies of a patient with xanthinuria and pheochromocytoma. Amer. J. Med., 37: 839: 1964.
7.
HarbaughJ. T.: Dissolution of renal calculus with allopurinol. J. Urol., 100: 412: 1968.
8.
ScottJ. T., HallA. P., GrahameR.: Allopurinol in the treatment of gout. Brit. Med. J., 2: 321: 1966.
9.
YuT. F., GutmanA. B.: Effect of allopurinol (4-hydroxipyrazolo (3, 4-d) pyrimidine) on serum and urinary acid uric in primary and secondary gout. Amer. J. Med., 37: 885: 1964.
